References
- Ahmadi, A., and Shadboorestan, A., 2016. Oxidative stress and cancer; the role of hesperidin, a citrus natural bioflavonoid, as a cancer chemoprotective agent. Nutrition and cancer, 68 (1), 29–39.
- Alasvand, N., et al., 2017. Therapeutic nanoparticles for targeted delivery of anticancer drugs. In: Alexandru Mihai Grumezescu, ed. Multifunctional systems for combined delivery, biosensing and diagnostics. Amsterdam: Elsevier, 245–259.
- Ali, S.H., et al., 2019. Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity. Artificial cells, nanomedicine, and biotechnology, 47 (1), 378–394.
- Arbain, N.H., et al., 2019. In vitro evaluation of the inhalable quercetin loaded nanoemulsion for pulmonary delivery. Drug delivery and translational research, 9 (2), 497–507.
- Chernyy, V., et al., 2018. Increased expression of miR-155 and miR-222 is associated with lymph node positive status. Journal of Cancer, 9 (1), 135–140.
- Cincin, Z.B., et al., 2018. Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 103, 336–345.
- Colombo, M., et al., 2018. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro. International journal of pharmaceutics, 543 (1–2), 214–223.
- Danaei, M., et al., 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10 (2), 57.
- Deshmukh, R., et al., 2021. Nanoemulsion: a snapshot on development, characterisation, applications, patents and clinical trials. International journal of pharmaceutical sciences and research, 12 (4), 1978–1988.
- Fam, S.Y., et al., 2020. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials, 10, 787.
- Ferrari, P.C., et al., 2019. Hesperidin-loaded solid lipid nanoparticles: development and physicochemical properties evaluation . Journal of nanoscience and nanotechnology, 19 (8), 4747–4757.
- Ganta, S., et al., 2014. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy. AAPS pharmscitech, 15 (3), 694–708.
- Hajialyani, M., et al., 2019. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules, 24 (3), 648.
- Hana, R.S., and Bawi, B.L., 2018. Hesperidin inhibits angiogenesis, induces apoptosis, and suppresses laryngeal cancer cell metastasis. Ibnosina journal of medicine and biomedical sciences, 10 (5), 169.
- Hanna, J., Hossain, G.S., and Kocerha, J., 2019. The potential for microRNA therapeutics and clinical research. Frontiers in genetics, 10, 478.
- Hao, B., and Zhang, J., 2019. miRNA-21 inhibition suppresses the human epithelial ovarian cancer by targeting PTEN signal pathway. Saudi journal of biological sciences, 26 (8), 2026–2029.
- Hassan, D., et al., 2019. Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections. International journal of pharmaceutics, 558, 143–156.
- Hassan, D., et al., 2020. Formulation of pH-responsive quatsomes from quaternary bicephalic surfactants and cholesterol for enhanced delivery of vancomycin against methicillin-resistant Staphylococcus aureus. Pharmaceutics, 12 (11), 1093.
- Hsu, H.J., et al., 2017. Preparation of carotenoid extracts and nanoemulsions from Lycium barbarum L. and their effects on growth of HT-29 colon cancer cells. Nanotechnology, 28 (13), 135103.
- Jaudan, A., et al., 2018. Induction of apoptosis by pinostrobin in human cervical cancer cells: possible mechanism of action. PLoS one, 13 (2), e0191523.
- Khames, A., 2019. Formulation and characterisation of Eplerenone nanoemulsion liquisolids, an oral delivery system with higher release rate and improved bioavailability. Pharmaceutics, 11 (1), 40.
- Khan, H., et al., 2021. Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects. Seminars in cancer biology, 69, 200–211.
- Khan, I., et al., 2018a. In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis. Scientific reports, 8 (1), 115–144.
- Khan, I., et al., 2018b. Carvacrol nanoemulsion evokes cell cycle arrest, apoptosis induction and autophagy inhibition in doxorubicin resistant-A549 cell line. Artificial cells, nanomedicine, and biotechnology, 46 (sup1), 664–675.
- Leichter, A.L., et al., 2017. MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Molecular cancer, 16 (1), 15.
- Li, C.-Y., et al., 2021. Cell cycle arrest and apoptosis induction by Juniperus communis extract in esophageal squamous cell carcinoma through activation of p53-induced apoptosis pathway. Food science & nutrition, 9 (2), 1088–1098.,
- Li, X., et al., 2018. Cell cycle arrest and apoptosis in HT-29 cells induced by dichloromethane fraction from Toddalia asiatica (L.) Lam. Frontiers in pharmacology, 9, 629.
- Liu, J., et al., 2015. Expression and function of miR-155 in breast cancer. Biotechnology & biotechnological equipment, 29 (5), 840–843.
- Lucca, L.G., et al., 2020. Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion. Arabian journal of chemistry, 13 (2), 4505–4511.
- Magura, J., et al., 2020. Phytochemical constituents and in vitro anticancer screening of isolated compounds from Eriocephalus africanus. Natural product research. https://doi.org/https://doi.org/10.1080/14786419.2020.1744138.
- Md, S., et al., 2020. Formulation design, statistical optimisation, and in vitro evaluation of a naringenin nanoemulsion to enhance apoptotic activity in A549 lung cancer cells. Pharmaceuticals, 13 (7), 152.
- Miyake, M., et al., 2018. Membrane permeation of giant unilamellar vesicles and corneal epithelial cells with lipophilic vitamin nanoemulsions. Colloids and surfaces. B, biointerfaces, 169, 444–452.
- Murad, H., et al., 2016. Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa. Cancer cell international, 16 (1), 39.
- Muralidharan, P., et al., 2014. Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers. Pharmaceutics, 6 (2), 333–353.
- O'Bryan, S., et al., 2017. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer. European journal of cancer, 72, 1–11.
- Pandey, P., et al., 2019. Hesperidin induces ROS-Mediated apoptosis along with cell cycle arrest at G2/M phase in human gall bladder carcinoma. Nutrition and cancer, 71 (4), 676–687.
- Periasamy, V.S., Athinarayanan, J., and Alshatwi, A.A., 2016. Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells. Ultrasonics sonochemistry, 31, 449–455.
- Price, C., and Chen, J., 2014. MicroRNAs in cancer biology and therapy: current status and perspectives. Genes & diseases, 1 (1), 53–63.
- Sánchez López, E., et al., 2019. Current applications of nanoemulsions in cancer therapeutics. Nanomaterials, 9 (6), 821.
- Schmittgen, T.D., and Livak, K.J., 2008. Analyzing real-time PCR data by the comparative C(T) method. Nature protocols, 3 (6), 1101–1108.
- Solans, C., Morales, D., and Homs, M., 2016. Spontaneous emulsification. Current opinion in colloid & interface science, 22, 88–93.
- Sulaiman, G.M., Jabir, M.S., and Hameed, A.H., 2018. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity. Artificial cells, nanomedicine, and biotechnology, 46 (sup1), 708–720.
- Tsirigotis-Maniecka, M., et al., 2017. Microencapsulation of hesperidin in polyelectrolyte complex microbeads: physico-chemical evaluation and release behavior. Journal of food engineering, 214, 104–116.
- Ullah, A., et al., 2020. Important flavonoids and their role as a therapeutic agent. Molecules, 25 (22), 5243.
- Wang, P., Du, Y., and Wang, J., 2019. Indentification of breast cancer subtypes sensitive to HCQ-induced autophagy inhibition . Pathology, research and practice, 215 (10), 152609.
- Wang, W., and Luo, Y.-P., 2015. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential. Journal of Zhejiang University. Science. B, 16 (1), 18–31.
- Wei, Q., Keck, C.M., and Müller, R.H., 2018. Solidification of hesperidin nanosuspension by spray drying optimized by design of experiment (DoE). Drug development and industrial pharmacy, 44 (1), 1–12.
- Werzer, O., et al., 2019. Drug release from thin films encapsulated by a temperature-responsive hydrogel. Soft matter royal matter, 15 (8), 1853–1859.
- Xu, J., et al., 2019. Development of hydrophilic drug encapsulation and controlled release using a modified nanoprecipitation method. Processes, 7 (6), 331.
- Yu, L., Zhao, J., and Gao, L., 2018. Predicting potential drugs for breast cancer based on miRNA and tissue specificity. International journal of biological sciences, 14 (8), 971–982.
- Zhang, J., et al., 2018. Lipid-polymer hybrid nanoparticles for oral delivery of tartary buckwheat flavonoids. Journal of agricultural and food chemistry, 66 (19), 4923–4932.
- Zhang, Y., et al., 2018. Convenient preparation of charge-adaptive chitosan nanomedicines for extended blood circulation and accelerated endosomal escape. Nano research, 11 (8), 4278–4292.
- Zhang, Y., et al., 2019. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155. Annals of hepatology, 18 (3), 494–500.